The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach
Lurasidone (LUR) is an antipsychotic drug whose interaction with human serum albumin (HSA) plays a crucial role in its pharmacokinetic and pharmacodynamic properties. A thorough understanding of LUR’s binding mechanism to HSA is crucial for predicting its transport, distribution, and potential drug...
Saved in:
| Main Authors: | Nevena Živković, Emina Mrkalić, Ratomir Jelić, Jovica Tomović, Jadranka Odović, Marina Ćendić Serafinović, Miroslav Sovrlić |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/7/1420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioequivalence study of two formulations of lurasidone film coated tablets in healthy subjects under fed conditions
by: Gökçe Sözer, et al.
Published: (2025-07-01) -
Changes in the pharmacokinetics of lurasidone in a pregnant woman with schizophrenia
by: Mihoko Kawai, et al.
Published: (2024-12-01) -
Lurasidone induces developmental toxicity and behavioral impairments in zebrafish embryos
by: Wentian Li, et al.
Published: (2025-07-01) -
Lurasidone for Pediatric Bipolar Disorder: A Systematic Review
by: Alexia Koukopoulos, et al.
Published: (2025-06-01) -
Identification of lurasidone as a potent inhibitor of severe fever with thrombocytopenia syndrome virus by targeting the viral nucleoprotein
by: Ting Cheng, et al.
Published: (2025-04-01)